Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

What Pharma Companies Need to Know Before Designing an Adaptive Clinical Trial

August 31, 2018

By John Balser, PhD, President, Mark Chang, PhD, Senior Vice President, and Robin Bliss, PhD, Director

The Food and Drug Administration (FDA) has started encouraging the use of adaptive designs for clinical studies. In essence, adaptive designs allow prospectively planned modifications to a clinical trial based on interim data, provided scientific validity (the ability to draw sound inferences) and data integrity (credibility and reproducibility) are preserved. 

Read More

What Drives Clinical Trial Quality Today?

October 18, 2017

Explore What We Learned at the 8th Clinical Quality Oversight Forum 

Veristat’s Senior Director of Corporate Compliance attended the 8th Clinical Quality Oversight Forum, an annual conference which took place 10-13 October 2017 in Philadelphia, PA.   

Read More